CD19 and acute lymphoblastic leukemia: To understand how IKAROS modulates CD19 surface expression, we analyzed isogenic IKAROS wild-type (WT) and knockdown (KD) B-ALL cell lines using ATAC-seq and RNA-seq (Supplementary Fig. 4E).